![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
| Medicamento que se usa en el tratamiento de la diabetes tipo 2 y que está en estudio para la prevención del cáncer de cabeza y de cuello. Podría prevenir que la leucoplaquia (afección precancerosa que afecta la boca) se convierta en cáncer. Es un tipo de tiazolidinediona. También se llama Actos. |
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20081011085829im_/http://www.nci.nih.gov/images/spacer.gif) |